ATE348842T1 - Anti-pilyrosporum ovale igy und dessen verwendung - Google Patents

Anti-pilyrosporum ovale igy und dessen verwendung

Info

Publication number
ATE348842T1
ATE348842T1 AT02718674T AT02718674T ATE348842T1 AT E348842 T1 ATE348842 T1 AT E348842T1 AT 02718674 T AT02718674 T AT 02718674T AT 02718674 T AT02718674 T AT 02718674T AT E348842 T1 ATE348842 T1 AT E348842T1
Authority
AT
Austria
Prior art keywords
ovale
pityrosporum ovale
igy
lgy
pilyrosporum
Prior art date
Application number
AT02718674T
Other languages
English (en)
Inventor
Jong-Hwa Lee
Jung Sakong
Dong-Il Jang
Chang-Seon Yu
Jin-Hee Jun
Original Assignee
Cotde Inc
Lee & Joe Biotech Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cotde Inc, Lee & Joe Biotech Co filed Critical Cotde Inc
Application granted granted Critical
Publication of ATE348842T1 publication Critical patent/ATE348842T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Hydroponics (AREA)
  • External Artificial Organs (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AT02718674T 2001-04-14 2002-04-15 Anti-pilyrosporum ovale igy und dessen verwendung ATE348842T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2001-0020004A KR100446856B1 (ko) 2001-04-14 2001-04-14 항비듬균 면역항체와 그 용도

Publications (1)

Publication Number Publication Date
ATE348842T1 true ATE348842T1 (de) 2007-01-15

Family

ID=19708259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718674T ATE348842T1 (de) 2001-04-14 2002-04-15 Anti-pilyrosporum ovale igy und dessen verwendung

Country Status (8)

Country Link
EP (1) EP1379556B1 (de)
JP (1) JP4002187B2 (de)
KR (1) KR100446856B1 (de)
CN (1) CN1524091A (de)
AT (1) ATE348842T1 (de)
DE (1) DE60216906T8 (de)
ES (1) ES2274966T3 (de)
WO (1) WO2002083737A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2746394A4 (de) 2011-08-19 2015-07-15 Ostrich Pharma Kk Antikörper und antikörper enthaltende zusammensetzung
WO2018026604A1 (en) * 2016-08-01 2018-02-08 Scaled Microbiomics, Llc Systems and methods for altering microbiome to reduce disease risk and manifestations of disease
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
JP2021523454A (ja) 2018-05-17 2021-09-02 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 毛髪分析のためのシステム及び方法
MX2020012225A (es) 2018-05-17 2021-01-29 Procter & Gamble Sistemas y metodos para el analisis de la cobertura del cabello.
WO2020005326A1 (en) * 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for personal care applications
JP7226766B2 (ja) * 2018-10-17 2023-02-21 オーストリッチファーマ株式会社 毛髪の改善のための抗体
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
EP3956451A1 (de) 2019-04-16 2022-02-23 The Procter & Gamble Company Aptamere für geruchsunterdrückungsanwendungen
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications
CN119242592B (zh) * 2024-10-16 2025-12-05 江南大学 一种分泌甘宝素单克隆抗体的杂交瘤细胞株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271682B (it) * 1994-07-19 1997-06-04 Indena Spa Determinazione e isolamento di taxolo e 10-desacetil-bacatina iii e analoghi attraverso anticorpi
DE60019309T2 (de) * 1999-09-16 2005-09-22 Unilever Plc Abgabesystem für ein mittel gegen schuppen

Also Published As

Publication number Publication date
EP1379556A1 (de) 2004-01-14
KR100446856B1 (ko) 2004-09-04
ES2274966T3 (es) 2007-06-01
KR20020079238A (ko) 2002-10-19
EP1379556A4 (de) 2005-02-09
DE60216906D1 (de) 2007-02-01
JP2005502594A (ja) 2005-01-27
EP1379556B1 (de) 2006-12-20
JP4002187B2 (ja) 2007-10-31
CN1524091A (zh) 2004-08-25
WO2002083737A1 (en) 2002-10-24
DE60216906T8 (de) 2008-01-17
DE60216906T2 (de) 2007-07-26

Similar Documents

Publication Publication Date Title
EA200401198A1 (ru) АНТИТЕЛА ПРОТИВ αvβ6
DE60329489D1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
NO20085104L (no) Antagonistisk anti-humant CD40-monoklonalt antistoff
EA200800812A1 (ru) Композиции антитела против cd3
ATE419009T1 (de) Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
NO20063224L (no) Anti-MPL-antistoff
NO20071188L (no) Humaniserte anti-cMet-antagonister
TW200714290A (en) Anti-M-CSF antibody compositions having reduced levels of endotoxin
ZA202209119B (en) Anti-human cd19 antibodies
DE60216906D1 (de) Anti-pilyrosporum ovale igy und dessen verwendung
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
DE60235588D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
SA523451582B1 (ar) Ccr8 الأجسام المضادة لـ
CR20220505A (es) Anticuerpos anti-phf-tau y usos de estos
NZ595863A (en) Antibodies to egfl7 and methods for their use
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
WO2002062972A3 (en) Hybridoma cell line g250 and its use for producing monoclonal antibodies
ATE370163T1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
ATE208403T1 (de) Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
WO2004087759A3 (en) Method and compositions for conversion of antibody activity
WO2021058795A3 (en) Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties